1. Introduction
Over the past 25 years, worldwide there has been a dramatic increase in the number of bed bug infestations, including both the common (
Cimex lectularius L.) and tropical (
Cimex hemipterus [F.]) species [
1,
2]. Numerous suggestions have been offered to account for the return of this public health pest [
3]. However, it is now recognised that insecticide resistance has been the main contributing cause [
2,
4]. Resistance in bed bugs has been widely reported to multiple insecticide classes [
1,
5,
6,
7]. Unfortunately, most of the insecticides registered for bed bug control around the globe today belong to those groups that have demonstrated resistance [
1,
6]. This has meant that control is a major challenge and treatment failures have been common. Nevertheless, insecticide application is still a universally mentioned method in modern bed bug management [
8]. Therefore, there is an urgent need for new insecticides to be available for the control of resistant bed bug strains.
Broflanilide [N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-6-(trifluoromethyl)phenyl]-2-fluoro-3-(N-methylbenzamido)benzamide] is a novel insecticide recently discovered by Mitsui Chemicals Agro, Inc., Japan [
9]. Broflanilide has a unique chemical structure characterized as a meta-diamide targeting the gamma-aminobutyric acid (GABA) gated chloride channel in the insect nervous system, resulting in a block of inhibitory neurotransmissions, convulsions, and death [
9]. Broflanilide has been classified by the Insecticide Resistance Action Committee (IRAC) as a GABA-gated chloride channel allosteric modulator (IRAC Group 30)[
10]. Broflanilide has been reported to have excellent efficacy against a range of insect pests including multiple-insecticide resistant strains, such as against the malaria mosquito (
Anopheles gambiae Giles 1902) [
11], wireworm (
Agriotes obscurus L. 1758) [
12], cotton bollworm (
Helicoverpa armigera Hübner 1808) and beet armyworm (
Spodoptera exigua Hübner 1808) [
13]. Multiple formulations of the insecticide have been produced for the control of urban pests, including a wettable powder (e.g., VECTRON™ T500) for mosquito control, aerosols (e.g., PT
® VediraTM Pressurized Insecticide and Iyana Mushi ZEROeKNIGHT One Push Spray for 60 times use [IMZOPS 60]), a fumigant for bed bug control (e.g., Iyana Mushi ZEROeKNIGHT for 10–13 m
2), as well as various formulations to control agricultural pests (Cimegra
® SC and Teraxxa
TM F4 seed treatment [Liquid]).
Broflanilide has been registered for bed bug control for some time (e.g., Australia since 2019) [
14], however no publication has appeared on the efficacy of the chemical against insecticide susceptible and resistant bed bug strains. Therefore, in this study we investigated: 1) the susceptibility of technical grade broflanilide and efficacy of a broflanilide-based aerosol formulation (IMZOPS 60) against insecticide susceptible and resistant bed bug
C. lectularius strains; 2) the effect of surface substrate (porous versus non-porous) and aging upon the efficacy of IMZOPS 60 against
C. lectularius, and; 3) the behavioral response of
C. lectularius to areas treated with IMZOPS 60.
4. Discussion
This study is the first report to examine the susceptibility of the common bed bug,
Cimex lectularius to broflanilide. The experiments demonstrated that the resistant SYD, DARL, and RIPPO strains of the common bed bug,
C. lectularius were susceptible to broflanilide, when compared to the reference susceptible MONH strain. The resistant PARRA
C. lectularius strain was slightly more tolerant to broflanilide, which may be due to a form of insecticide resistance. For this strain, cuticular, metabolic, and knockdown resistance has previously been reported [
16,
25,
26]. While it is unlikely that the knockdown resistance would not contribute to any tolerance (due to the mode of action), the presence of a thicker cuticle is likely to slow down the penetration of the insecticide into the insect, thereby leading to a higher resistance ratio [
1]. However, it is also important to note that the recorded resistance ratio for the PARRA strain against broflanilide of 3.65-fold is still extremely low in comparison to other insecticides. For example, the Sydney strain of
Cimex lectularius against permethrin, was found to have a resistance ratio of 1,235,000 [
27].
Historically, the common bed bug
C. lectularius has largely been distributed in temperate regions, while the tropical bed bug
C. hemipterus, has mainly been confined to tropical and subtropical regions [
15]. Recently, the distribution of two bed bug species have increasingly overlapped [
1,
28].
Cimex hemipterus has been recorded in temperate regions over last decade, including Central Europe [
29], France [
30], Korea [
31], Russia (Moscow, Smolensk, Saransk, and St Petersburg [
32], and Voronezh [
33]), and the UK [
34]. The two bed bug species display varying resistance levels and resistance mechanisms to insecticides [
1,
35,
36], with
Cimex hemipterus having higher levels of resistance to insecticides than
C. lectularius [
36,
37,
38]. Therefore, considering this, studies into the susceptibility of
C. hemipterus to broflanilide are warranted prior to field use against this species.
As modern field strains of bed bugs are resistant to most classes of insecticides [
6], products containing actives with new modes of action are urgently needed for bed bug management. Broflanilide appeared to be a potentially promising candidate as it is a novel insecticide with a unique mode of action (IRAC Group 30). This was confirmed with the studies herein, demonstrating that
C. lectularius, including modern field strains, were highly susceptible to broflanilide, and hence the active is a viable choice for the management of these insects. Our laboratory evaluations also confirmed the efficacy of a broflanilide-based aerosol product (IMZOPS 60) to one susceptible and four resistant
C. lectularius strains (both as a direct topical spray and as a dry residual residue). The experiments demonstrated that IMZOPS 60 is highly effective at killing both susceptible and resistance strains, as well as eggs and first instars. In the direct spray assays, IMZOPS 60 resulted in 100% mortality of all test bed bugs (susceptible and resistant strains) within 24 hrs post-treatment, excepting the resistant PARRA strain, which had 100% mortality after 48 hrs post-treatment. Egg hatch rates of both susceptible (MONH) and resistant (PARRA) strains were significantly reduced with IMZOPS 60 spray, and were comparable in terms of efficacy with both strains.
Previous studies have found that a broflanilide formulation (Tenebenal™) has slower residual efficacy against mosquitoes, compared with most widely employed insecticides, such as the pyrethroids [
17]. Similarly, our residual assays found that residues of IMZOPS 60 on both smooth non-porous (ceramic tiles) and porous (filter paper) surfaces have a slower effect on bed bugs. For example, it took up to 3 days for all the first instars of both MONH and PARRA strains to die following residual exposure. In the case of the adult insects, the residues on tiles and filter paper resulted in high mortality to the susceptible MONH, and the resistant SYD, DARL, PARRA and RIPPO strains within 3 days of exposure. However, excluding the PARRA strain, all strains achieved 100% mortality within 7 days (MONH=2–3 days, SYD=5–6 days, DARL=4–6 days, RIPPO=6–7 days). With the PARRA strain when exposed to IMZOPS 60, mortality reached 100% after 3 days exposure on the tiles, and 97.5% on filter paper after 7 days constant exposure. Considering the slow efficacy observed, a repeated inspection after 7 days post-treatment should be considered as best practice in bed bug management using broflanilide-based products.
The residual experiments conducted herein, were all forced exposure trials. However, in the field, it may be that bed bugs will not be constantly confined to insecticide treated areas, as the insects harbor in cracks and crevices where insecticide penetration is challenging to achieve. Therefore, the influences of exposure time and mortality assessment interval, as per Leong and colleagues [
39], should be investigated in future efficacy studies involving broflanilide. Fortunately,
C. lectularius did not avoid surfaces treated with the insecticide, which will ensure a longer exposure with through applications.
Compared to the nymphs and adults of bed bugs, relatively little research has been undertaken on the resistance status of the egg stage [
40]. However, the age of the eggs can vary in resistance to insecticides due to the combined effects of the eggshell development and resistant mechanisms [
40,
41,
42]. Compared to the susceptible Harlan
C. lectularius strain, Campbell and Miller [
41] found that eggs of two pyrethroid-resistant
C. lectularius strains were resistant to imidacloprid/β-cyfluthrin (Temprid SC) with 3- and 5.1-fold difference in the LC
50, and to acetamiprid/bifenthrin (Transport GHP) with 39- and 1,080-fold difference in the LC
50. Hinson and colleagues (2016) [
40] found that Temprid SC was the most effective insecticide at preventing egg hatch (13% hatch rate) for a pyrethroid-resistant
C. lectularius strain, compared to the insecticides of Bedlam (MGK-264, sumithrin [84% hatch rate]), Demand CS (lambda-cyhalothrin [91% hatch rate]), and Phantom SC (chlorfenapyr [95% hatch rate]). Compared to the susceptible Monheim
C. lectularius strain, Leong and colleagues (2021) [
42] also found that eggs from five pyrethroid-resistant
C. hemipterus strains showed high to very high resistance against the insecticides of Tandem M (thiamethoxam/lambda-cyhalothrin), Temprid SC, Sumithion CS (fenitrothion), Pesguard FG161 EC (d-tetramethrin/cyphenothrin), and Sumthrin ME (d-phenothrin). In comparison, our studies found that the broflanilide-based aerosol (IMZOPS 60) resulted in low egg hatch rates for the resistant PARRA strain (14.9–22.6%), which was similar to the susceptible (MONH) strain (9.7–23.4%). With most aerosols, the constant pressing of the actuator (trigger or button) results in a continual flow of spray. In contrast, the flow stops once the actuator of IMZOPS 60 is fully depressed, meaning that the action is more like a pump-style aerosolizer. Perhaps this pump-style aerosolizer may have resulted in uneven spraying of the IMZOPS 60 on the bed bug eggs, leading to eegs being untreated and hence a small number of eggs from both MONH and PARRA strains hatching. However, because of the high residual efficacy, the residues of IMZOPS 60 still will kill the first instars that subsequently hatch. Consequently, IMZOPS 60 can be considered an effective ovicide for bed bug management.
The type of substrate surface (e.g., non-porous versus porous) has been found to affect the residual efficacy of insecticides against pests including bed bugs [
36,
43,
44,
45]. Generally, liquid insecticides applied on a non-porous surface provides higher performance than a porous surface. For example, Wang and colleagues [
46] revealed that the residual efficacy of Tandem on vinyl (non-porous) was higher than that on fabric (porous) against
C. lecularius, although the residual efficacy of Temprid SC, Transport GHP and Demand CS on vinyl was similar to that on fabric. Dang and colleagues [
36] found that both Temprid SC and Tandem residues on glass surface killed resistant
C. hemipterus strains significantly faster than that on filter paper. The residues of Temprid SC and Tandem on filter paper failed to control bed bugs for the duration of the experiment with mortality less than 50% after 120 h of continual exposure. Compared with liquid insecticides, the performance of aerosol formulated insecticides applied on various substrates against bed bugs can be unpredictable [
46]. Furthermore, in the field, insecticide applications for bed bug management are typically applied onto porous surface substrates, particularly as bed bugs tend to avoid smooth non-porous surfaces [
46]. It is worth noting that our studies found that different substrates sprayed with IMZOPS 60 had little impact on overall residual mortality, although the time to achieve complete mortality was slightly longer on the filter paper compared to the tiles.
Aging is known to impact the residual efficacy of insecticides, especially against bed bugs [
36,
47]. However, aging residually treated surfaces to six months had little impact with the residual efficacy of IMZOPS 60. Our studies found that the residues of IMZOPS 60 on tiles and filter paper that were aged indoors for 1 WEEK, 2 WEEKS, 4 WEEKS, 3 MONTHS, and 6 MONTHS, were all equally effective as fresh residues (1 DAY). Our results confirmed previous investigations that found broflanilide-based formulation had long residual activity on the surfaces of ceramic, wood, and cement tiles, against mosquitoes (Lee et al. 2020) [
17]. As noted above, the behavioral response assays revealed that
C. lectularius from the susceptible MONH and resistant PARRA strains did not avoid surfaces treated by IMZOPS 60. This means that with the long residual life of the insecticide and the non-avoidance of treated residues by
C. lectularius, broflanilide will aid in reducing the need for repeated applications of the insecticide. An added benefit will be the prevention of new infestations in areas previously treated with the product. In highly infested locations such as low-income housing, broflanilide products could be applied prophylactically to prevent the establishment of new infestations, and ultimately should significantly reduce control costs.
Figure 1.
Arenas for behavioral responses to harborages treated with IMZOPS 60. (B) Arena for one-choice assay; (A). Arena for two-choice assay.
Figure 1.
Arenas for behavioral responses to harborages treated with IMZOPS 60. (B) Arena for one-choice assay; (A). Arena for two-choice assay.
Figure 2.
Mortality (mean±SD) of the susceptible MONH strain and four resistant strains after 24 h post-treatment. Lowercase letters (a) above each column indicate no statistical difference (one-way ANOVA, Turkey’s test, P > 0.05).
Figure 2.
Mortality (mean±SD) of the susceptible MONH strain and four resistant strains after 24 h post-treatment. Lowercase letters (a) above each column indicate no statistical difference (one-way ANOVA, Turkey’s test, P > 0.05).
Figure 3.
Hatch rates of three groups of the MONH and PARRA eggs. GROUP ONE = control, including MONH-CONTROL and PARRA-CONTROL. GROUP TWO = 1–2 days old eggs treated by IMZOPS 60, including MONH-TREATED (1-2 DAYS) and PARRA-TREATED (1-2 DAYS). GROUP THREE = 4–5 days old eggs treated by IMZOPS 60, including MONH-TREATED (4-5 DAYS) and PARRA-TREATED (4-5 DAYS). Lowercase letters (a, b) adjacent to the error bars indicate statistical differences (one-way ANOVA, Turkey’s test, P < 0.05).
Figure 3.
Hatch rates of three groups of the MONH and PARRA eggs. GROUP ONE = control, including MONH-CONTROL and PARRA-CONTROL. GROUP TWO = 1–2 days old eggs treated by IMZOPS 60, including MONH-TREATED (1-2 DAYS) and PARRA-TREATED (1-2 DAYS). GROUP THREE = 4–5 days old eggs treated by IMZOPS 60, including MONH-TREATED (4-5 DAYS) and PARRA-TREATED (4-5 DAYS). Lowercase letters (a, b) adjacent to the error bars indicate statistical differences (one-way ANOVA, Turkey’s test, P < 0.05).
Figure 4.
Kaplan–Meier survival analyses for the residual efficacy of IMZOPS 60 on tiles (A) and filter paper (B) against the five strains of C. lectularius. MS = median survival time (day). Lowercase letters (a, b) following the values of MS indicate statistical differences between the susceptible strain and each resistant strain (Log-rank test, P value is less than α, [α = 0.05/4, Bonferroni correction, 4 is the number of pairwise comparisons (e.g., MONH vs SYD, MONH vs DARL, MONH vs PARRA, MONH vs RIPPO) of survival curves in either (A) or (B)]).
Figure 4.
Kaplan–Meier survival analyses for the residual efficacy of IMZOPS 60 on tiles (A) and filter paper (B) against the five strains of C. lectularius. MS = median survival time (day). Lowercase letters (a, b) following the values of MS indicate statistical differences between the susceptible strain and each resistant strain (Log-rank test, P value is less than α, [α = 0.05/4, Bonferroni correction, 4 is the number of pairwise comparisons (e.g., MONH vs SYD, MONH vs DARL, MONH vs PARRA, MONH vs RIPPO) of survival curves in either (A) or (B)]).
Figure 5.
Mortality (mean±SD %) of all five strains after 3 days exposure on the residues of either tiles (A) or filter paper (B). Lowercase letters (a, b) above the error bars indicate statistical differences (one-way ANOVA, Turkey’s test, P < 0.05).
Figure 5.
Mortality (mean±SD %) of all five strains after 3 days exposure on the residues of either tiles (A) or filter paper (B). Lowercase letters (a, b) above the error bars indicate statistical differences (one-way ANOVA, Turkey’s test, P < 0.05).
Figure 6.
Kaplan–Meier survival analyses for the residual efficacy of IMZOPS 60 on tiles (TILE) and filter paper (PAPER) against the first instars of MONH and PARRA strains. MS = median survival time (day). Lowercase letters (a, b, c) indicate statistical differences between each trial (Log-rank test, P value is less than α, [α=0.05/6, Bonferroni correction, 6 is the number of pairwise comparisons of survival curves (e.g., MONH-TILE vs PARRA-TILE, MONH-TILE vs MONH-PAPER, MONH-TILE vs PARRA-PAPER, PARRA-TILE vs MOMH-PAPER, PARRA-TILE vs PARRA-PAPER, MONH-PAPER vs PARRA-PAPER)]).
Figure 6.
Kaplan–Meier survival analyses for the residual efficacy of IMZOPS 60 on tiles (TILE) and filter paper (PAPER) against the first instars of MONH and PARRA strains. MS = median survival time (day). Lowercase letters (a, b, c) indicate statistical differences between each trial (Log-rank test, P value is less than α, [α=0.05/6, Bonferroni correction, 6 is the number of pairwise comparisons of survival curves (e.g., MONH-TILE vs PARRA-TILE, MONH-TILE vs MONH-PAPER, MONH-TILE vs PARRA-PAPER, PARRA-TILE vs MOMH-PAPER, PARRA-TILE vs PARRA-PAPER, MONH-PAPER vs PARRA-PAPER)]).
Figure 7.
Kaplan–Meier survival analyses for the efficacy of the aged residual IMZOPS 60 on tiles against MONH (A) and PARRA (B) strains. MS=median survival time (day). Lowercase letters (a,b) indicate statistical differences between the fresh residues and each aged residues (Log-rank test, P value is less than α, [α=0.05/5, Bonferroni correction, 5 is the number of pairwise comparisons (e.g., 1 DAY vs 1 WEEK, 1 DAY vs 2 WEEKS, 1 DAY vs 4 WEEKS, 1 DAY vs 3 MONTHS, and 1 DAY vs 6 MONTHS) of survival curves in either (A) or (B)]).
Figure 7.
Kaplan–Meier survival analyses for the efficacy of the aged residual IMZOPS 60 on tiles against MONH (A) and PARRA (B) strains. MS=median survival time (day). Lowercase letters (a,b) indicate statistical differences between the fresh residues and each aged residues (Log-rank test, P value is less than α, [α=0.05/5, Bonferroni correction, 5 is the number of pairwise comparisons (e.g., 1 DAY vs 1 WEEK, 1 DAY vs 2 WEEKS, 1 DAY vs 4 WEEKS, 1 DAY vs 3 MONTHS, and 1 DAY vs 6 MONTHS) of survival curves in either (A) or (B)]).
Figure 8.
Kaplan–Meier survival analyses for the efficacy of the aged residual IMZOPS 60 on filter paper against MONH (A) and PARRA (B) strains. MS = median survival time (day). Lowercase letters (a) indicate no statistical differences between the fresh residues and each aged residue (Log-rank test, P value is more than α, [α=0.05/5, Bonferroni correction, 5 is the number of pairwise comparisons (e.g., 1 DAY vs 1 WEEK, 1 DAY vs 2 WEEKS, 1 DAY vs 4 WEEKS, 1 DAY vs 3 MONTHS, and 1 DAY vs 6 MONTHS) of survival curves in either (A) or (B)]).
Figure 8.
Kaplan–Meier survival analyses for the efficacy of the aged residual IMZOPS 60 on filter paper against MONH (A) and PARRA (B) strains. MS = median survival time (day). Lowercase letters (a) indicate no statistical differences between the fresh residues and each aged residue (Log-rank test, P value is more than α, [α=0.05/5, Bonferroni correction, 5 is the number of pairwise comparisons (e.g., 1 DAY vs 1 WEEK, 1 DAY vs 2 WEEKS, 1 DAY vs 4 WEEKS, 1 DAY vs 3 MONTHS, and 1 DAY vs 6 MONTHS) of survival curves in either (A) or (B)]).
Figure 9.
Daily recorded number (mean±SD %) of the MONH C. lectularius strain on and/or under harborages, wandering, and dead in one-choice harborage assays. Either lowercase letters (a, b) or uppercase letters (A, B) above the error bars indicate statistical differences in each individual day (two-way ANOVA, Turkey’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Figure 9.
Daily recorded number (mean±SD %) of the MONH C. lectularius strain on and/or under harborages, wandering, and dead in one-choice harborage assays. Either lowercase letters (a, b) or uppercase letters (A, B) above the error bars indicate statistical differences in each individual day (two-way ANOVA, Turkey’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Figure 10.
Daily recorded number (mean±SD %) of the PARRA C. lectularius strain on and/or under harborages, wandering, and death in one-choice harborage assays. Either lowercase letters (a, b) or uppercase letters (A, B) above the error bars indicate statistical difference in each individual day (two-way ANOVA, Turkey’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Figure 10.
Daily recorded number (mean±SD %) of the PARRA C. lectularius strain on and/or under harborages, wandering, and death in one-choice harborage assays. Either lowercase letters (a, b) or uppercase letters (A, B) above the error bars indicate statistical difference in each individual day (two-way ANOVA, Turkey’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Figure 11.
Daily recorded number (mean±SD %) of MONH strain C. lectularius on and/or under harborages (treated and blank), wandering, and death in two-choice harborage assays. Either lowercase letters (a,b) or uppercase letters (A,B) above the error bars indicate statistic difference in each individual day (two-way ANOVA, Šídák’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Figure 11.
Daily recorded number (mean±SD %) of MONH strain C. lectularius on and/or under harborages (treated and blank), wandering, and death in two-choice harborage assays. Either lowercase letters (a,b) or uppercase letters (A,B) above the error bars indicate statistic difference in each individual day (two-way ANOVA, Šídák’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Figure 12.
Daily recorded number (mean±SD %) of PARRA strain C. lectularius on and/or under harborages, wandering, and death in two choice harborage assays. The harborages included treated harborages (TREATED) and untreated harborages (BLANK). Either lowercase letters (a, b) or uppercase letters (A, B) above the error bars indicate statistical difference in each individual day (two-way ANOVA, Šídák’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Figure 12.
Daily recorded number (mean±SD %) of PARRA strain C. lectularius on and/or under harborages, wandering, and death in two choice harborage assays. The harborages included treated harborages (TREATED) and untreated harborages (BLANK). Either lowercase letters (a, b) or uppercase letters (A, B) above the error bars indicate statistical difference in each individual day (two-way ANOVA, Šídák’s test, P < 0.05). As the focus of the trial was on the behavioral response of the insects to the chemical, bed bugs that died were not included in the statistical analyses.
Table 1.
Bed bug strains used in the study.
Table 1.
Bed bug strains used in the study.
Locations |
Strain code |
Year |
Maximum generation |
Susceptibility |
kdr Haplotypeb
|
Monheim, Germany, 40789 |
MONH |
1960s |
NA |
Susceptible |
A |
Sydney, NSW Australia, 2000 |
SYD |
2004 |
>200 |
Resistant |
A/B |
Darlinghurst, NSW Australia, 2010 |
DARL |
2011 |
140 |
Resistant |
B/C |
Parramatta, NSW Australia, 2150 |
PARRAa
|
2012 |
128 |
Resistant |
B |
Ripponlea, VIC Australia, 3185 |
RIPPO |
2013 |
117 |
Resistant |
B |
Table 2.
Log-dose probit-mortality data for a susceptible MONH strain and four pyrethroid resistant strains tested with Broflanilide.
Table 2.
Log-dose probit-mortality data for a susceptible MONH strain and four pyrethroid resistant strains tested with Broflanilide.
Strains |
Replicatesa |
Nb
|
LD50 ng (95%, CI)c
|
LD95 ng (95%, CI) |
χ2 (df) |
Slop ± SE |
RR50 d
|
MONH |
8 |
640 |
1.00 (0.38 – 1.76) A |
12.49 (5.29 – 166.16) |
25.72 (5) |
1.50 ± 0.14 |
1 |
SYD |
4 |
360 |
1.22 (0.46 – 2.17) AB |
91.69 (39.95 – 439.89) |
2.96 (4) |
0.88 ± 0.15 |
1.22 |
DARL |
5 |
450 |
1.03 (0.11 – 2.38) AB |
40.89 (14.79 – 972.74) |
7.42 (4) |
1.03 ± 0.16 |
1.03 |
PARRA |
8 |
720 |
3.65 (1.83 – 7.20) B |
137.58 (43.43 – 1648.30) |
26.45 (6) |
1.04 ± 0.08 |
3.65 |
RIPPO |
5 |
450 |
2.77 (1.52 – 4.35) AB |
283.06 (113.72 – 1346.70) |
3.34 (4) |
1.50 ± 0.19 |
2.77 |